Bridge Creek Capital Management LLC lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 79.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 28,567 shares of the company’s stock after purchasing an additional 12,660 shares during the period. Bridge Creek Capital Management LLC’s holdings in Henry Schein were worth $1,996,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in HSIC. YorkBridge Wealth Partners LLC raised its stake in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC raised its stake in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after purchasing an additional 573 shares in the last quarter. Cypress Capital Management LLC purchased a new stake in Henry Schein in the second quarter valued at approximately $217,000. FTB Advisors Inc. raised its stake in Henry Schein by 100.0% in the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after purchasing an additional 742 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after purchasing an additional 616 shares in the last quarter. 91.70% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein, Inc. (NASDAQ HSIC) traded down $1.73 during mid-day trading on Friday, hitting $74.62. 1,778,300 shares of the company’s stock traded hands, compared to its average volume of 1,639,008. The stock has a market capitalization of $11,900.00, a P/E ratio of 21.50, a PEG ratio of 1.95 and a beta of 0.99. Henry Schein, Inc. has a 52-week low of $65.28 and a 52-week high of $93.50. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing the consensus estimate of $0.90 by ($0.03). The business had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same period last year, the business posted $0.84 earnings per share. equities analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.

In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the transaction, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.19% of the company’s stock.

A number of brokerages recently weighed in on HSIC. Jefferies Group reaffirmed a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a research note on Friday, October 20th. Robert W. Baird set a $95.00 target price on shares of Henry Schein and gave the company a “buy” rating in a research note on Thursday, October 19th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a research note on Thursday, October 19th. Morgan Stanley began coverage on shares of Henry Schein in a research note on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 target price on the stock. Finally, Evercore ISI began coverage on shares of Henry Schein in a research note on Thursday, January 4th. They issued an “outperform” rating and a $81.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $84.23.

COPYRIGHT VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Stake Raised by Bridge Creek Capital Management LLC” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.dailypolitical.com/2018/01/19/henry-schein-inc-hsic-stake-raised-by-bridge-creek-capital-management-llc.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.